AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Jan 7, 2025
35599_dirs_2025-01-07_a3cbfc9a-f610-4828-96fe-d65904beaf79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-01-06
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-06 | Common shares | S | 2431 | $6.08 | Disposed | 91432 | Direct |
| 2025-01-06 | Common shares | S | 7569 | $6.08 | Disposed | 83863 | Direct |
Footnotes
F1: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.
F2: Shares acquired through the exercise of an option contract with strike price of $2.36 on August 13, 2020.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20